Corcept Therapeutics shares are trading higher as investors show resilience despite ongoing securities class action lawsuits and recent FDA setbacks related to the relacorilant application.

Viomi Technology shares are trading lower after the company reported a steep 25.9% decline in second half 2025 revenues compared to the same period in 2024, primarily due to reduced national subsidies for water purifiers.

Next Technology Holding Inc. shares are trading lower after the company announced a $157 million registered direct offering, diluting existing shareholder value.

MCVT shares are trading higher after Wellesley Asset Management launched the Miller Convertible Total Return ETF, emphasizing a disciplined, convertible-focused strategy.

Sarepta Therapeutics shares are trading higher after the company announced promising early clinical results from its Phase 1/2 studies of SRP-1001 and SRP-1003, suggesting potential efficacy in treating rare neuromuscular diseases.

Paysign shares are trading higher after the company announced a 40.5% increase in total revenue for 2025, driven by strong growth in its pharma and plasma segments, along with optimized operational efficiencies.

IMUNON shares are trading lower despite the company reporting positive Phase 2 clinical data showing an improvement in median overall survival for its lead drug candidate IMNN-001 in advanced ovarian cancer.

Quoin Pharmaceuticals shares are trading higher after the U.S. FDA indicated that a single Phase 3 study may be sufficient for QRX003's marketing approval for Netherton Syndrome, moving the company closer to potentially delivering the first approved treatment for the condition.

FiscalNote shares are trading higher after the company announced the approval and listing of its PolicyNote MCP in the OpenAI App Store, expanding its reach and market potential.

Cardlytics shares are trading higher after the company announced the completion of the sale of its Bridg business to PAR Technology, resulting in receiving 1,810,222 shares of PAR Technology common stock and strengthening its financial position.

Absci shares are trading lower after the company reported a significant increase in research and development expenses for Q4 2025, contributing to a net loss of $29.6 million, compared to the $29.0 million loss in the previous year.

DigitalOcean shares are trading lower after the company announced a $700 million underwritten public offering of its common stock.

Edible Garden shares are trading lower as investors await the upcoming financial results for Q4 and full year 2025, scheduled to be announced on March 31, 2026.

Draganfly shares are trading lower after the company reported an increase in revenue for Q4 and fiscal year 2025 but faced widening comprehensive losses due to higher expenses and reduced gross margins.

Arm Holdings shares are trading higher after the company announced its expansion into production silicon with the new Arm AGI CPU, aimed at addressing growing demand for AI-driven infrastructure.

Fractyl Health shares are trading higher after the company reported significant progress in its REMAIN-1 Pivotal Cohort with positive post-hoc analyses and received favorable FDA feedback on its De Novo classification request, boosting investor confidence.

Braze shares are trading higher after the company reported an over 50% year-over-year increase in quarterly bookings and announced a $100 million share repurchase program, highlighting strong enterprise segment performance and new product rollouts ahead of schedule.

Blaize Holdings shares are trading higher after the company reported a substantial increase in revenue, rising to $38.6 million in 2025, driven by expanding AI infrastructure engagements and a strategic focus on efficient inference systems.

LENZ Therapeutics shares are trading lower after the company reported a Q4 net loss of $35.9 million, driven by increased SG&A expenses despite growing prescriber uptake of its new product, VIZZ.

NeutronX shares are trading higher after the company appointed former Adobe Enterprise Architect Alex Gaber to advance its next-generation AI-enabled infrastructure systems.